IP Library Patent Application 11423399
Patent Application
App. No. 11/423,399

IMPROVED PRIMER-BASED AMPLIFICATION METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/423,399
Abstract

The present invention provides methods for amplifying a target nucleic acid with greater efficiency and accuracy by using one or more flap primers.

Claims (84)

1 . A method for amplification of a target nucleic acid in a sample, the method comprising:

(a) contacting a sample suspected of containing the target nucleic acid with an amplification reaction mixture comprising:

at least one flap primer having the formula:

5′-X—Y-3′  (I)

wherein X represents the 5′ sequence portion of the flap primer that is non-complementary to the target nucleic acid, Y represents the 3′ sequence portion of the flap primer that is complementary to the target nucleic acid, wherein X is from 3-40 nucleotides in length;

(b) incubating the reaction mixture under amplification conditions, thereby generating an amplified target nucleic acid; and

(c) optionally detecting the amplified target nucleic acid.

2 . The method of claim 1 , wherein a signal from the amplified target nucleic acid is at least about 1.25 to about 3-fold greater in comparison to a signal from an amplified target nucleic acid amplified in an amplification reaction mixture that does not comprise at least one flap primer.

3 . The method of claim 1 , wherein the amount of the amplified target nucleic acid is at least about 1.25 to about 3-fold greater in comparison an amount of an amplified target nucleic acid amplified in an amplification reaction mixture that does not comprise at least one flap primer.

4 . The method of claim 1 , wherein the reaction mixture comprises a forward flap primer and a reverse flap primer.

5 . The method of claim 1 , wherein Y comprises a larger number of nucleotides than X.

6 . The method of claim 1 , wherein X and Y are about an equal number of nucleotides in length.

7 . The method of claim 1 , wherein Y is more than 10 nucleotides in length.

8 . The method of claim 1 , wherein X is 9-15 nucleotides in length.

9 . The method of claim 8 , wherein X is 10-14 nucleotides in length.

10 . The method of claim 9 , wherein X is 11-13 nucleotides in length.

11 . The method of claim 10 , wherein X is 12 nucleotides in length.

12 . The method of claim 1 , wherein X comprises at least 70% adenine or thymine nucleotide bases, or modified bases thereof.

13 . The method of claim 12 , wherein X comprises at least 80% adenine or thymine nucleotide bases, or modified bases thereof.

14 . The method of claim 13 , wherein X comprises at least 90% adenine or thymine nucleotide bases, or modified bases thereof.

15 . The method of claim 1 , wherein the amplification of the target nucleic acid sequence is continuously monitored.

16 . The method of claim 1 , wherein the amplified target nucleic acid is detected via fluorescence-generating probe.

17 . The method of claim 16 , wherein the amplified target nucleic acid is detected via a hybridization-based fluorescent probe.

18 . The method of claim 16 , wherein the amplified target nucleic acid is detected via a DNA binding fluorescent compound.

19 . The method of claim 1 , wherein the target nucleic acid is selected from the group consisting of DNA, mRNA, tRNA and rRNA.

20 . The method of claim 1 , wherein the target nucleic acid is less than 30 nucleotides in length.

21 . The method of claim 20 , wherein the target nucleic acid is miRNA or siRNA.

22 . The method of claim 1 , further comprising

(c) contacting the amplified target nucleic acid of step (b) with reaction mixture comprising:

(i) a primer comprising a sequence complementary to the target nucleic acid of step (b); and

(ii) a primer comprising a sequence complementary to the target nucleic acid of step (b) and a minor groove binder; and

(d) incubating the reaction mixture of step (c) under amplification conditions, thereby generating a second amplified target nucleic acid; and

(e) optionally detecting the amplified target nucleic acid of step (d).

23 . The method of claim 22 , wherein the primer of step (c)(i) is a second flap primer of formula I.

24 . The method of claim 23 , wherein the first primer of formula I and the second flap primer of formula I are the same.

25 . The method of claim 22 , wherein the primer of step (c)(i) is a MGB-primer.

26 . The method of claim 22 , wherein the primer of step (c)(ii) is a detection primer further comprising a fluorophore, wherein the fluorophore is quenched by the MGB and insertion of the MGB into a minor groove unquenches the fluorophore.

27 . A method for amplification of a target nucleic acid in a sample, the method comprising:

(a) contacting the sample suspected of containing the target nucleic acid with an amplification reaction mixture comprising:

at least one flap primer comprising an annealed helper oligonucleotide and having the formula:

5′-X—Y-3′

3′-X′-5′  (II)

wherein X represents the 5′ sequence portion of the flap primer that is non complementary to the target nucleic acid, X′ represents the helper oligonucleotide sequence that is complementary to X and comprises at least one modified nucleoside base, and Y represents the 3′ sequence portion of the flap primer that is complementary to the target nucleic acid, wherein X is from 3-40 nucleotides in length;

(b) incubating the reaction mixture under amplification conditions, thereby generating an amplified target nucleic acid; and

(c) optionally detecting the amplified target nucleic acid.

28 . The method of claim 27 , wherein X′ comprises a smaller number of nucleoside bases than X.

29 . The method of claim 27 , wherein X′ comprises a nucleoside base selected from the group consisting of: 4-(4,6-Diamino-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-but-3-yn-1-ol (Super A); 6-Amino-3-(4-hydroxy-but-1-ynyl)-1,5-dihydro-pyrazolo[3,4-d-]pyrimidin-4-one; 5-(4-hydroxy-but-1-ynyl)-1H-pyrimidine-2,4-dione (Super T), and combinations thereof.

30 . The method of claim 27 , wherein the reaction mixture comprises a forward flap primer and a reverse flap primer.

31 . The method of claim 27 , wherein the forward flap primer and the reverse flap primer are independently selected from the group consisting of: Formula I and Formula II.

32 . The method of claim 27 , wherein Y comprises a larger number of nucleotides than X.

33 . The method of claim 27 , wherein X and Y are about an equal number of nucleotides in length.

34 . The method of claim 27 , wherein Y is more than 10 nucleotides in length.

35 . The method of claim 27 , wherein X is 9-15 nucleotides in length.

36 . The method of claim 35 , wherein X is 10-14 nucleotides in length.

37 . The method of claim 36 , wherein X is 11-13 nucleotides in length.

38 . The method of claim 37 , wherein X is 12 nucleotides in length.

39 . The method of claim 27 , wherein X comprises at least 70% adenine or thymine nucleotide bases, or modified bases thereof.

40 . The method of claim 39 , wherein X comprises at least 80% adenine or thymine nucleotide bases, or modified bases thereof.

41 . The method of claim 40 , wherein X comprises at least 90% adenine or thymine nucleotide bases, or modified bases thereof.

42 . The method of claim 27 , wherein the amplification of the target nucleic acid sequence is continuously monitored.

43 . The method of claim 27 , wherein the amplified target nucleic acid is detected via fluorescence-generating probe.

44 . The method of claim 43 , wherein the amplified target nucleic acid is detected via a hybridization-based fluorescent probe.

45 . The method of claim 43 , wherein the amplified target nucleic acid is detected via a DNA binding fluorescent compound.

46 . The method of claim 27 , wherein the target nucleic acid is selected from the group consisting of DNA, mRNA, tRNA and rRNA.

47 . The method of claim 27 , wherein the target nucleic acid is less than 30 nucleotides in length.

48 . The method of claim 47 , wherein the target nucleic acid is selected from the group consisting of siRNA and miRNA.

49 . The method of claim 27 , further comprising

(c) contacting the amplified target nucleic acid of step (b) with reaction mixture comprising:

(i) a primer comprising a sequence complementary to the target nucleic acid of step (b); and

(ii) a primer comprising a sequence complementary to the target nucleic acid of step (b)and a minor groove binder; and

(d) incubating the reaction mixture of step (c) under amplification conditions, thereby generating a second amplified target nucleic acid; and

(e) optionally detecting the amplified target nucleic acid of step (d).

50 . The method of claim 49 , wherein the primer of step (c)(i) is a second flap primer of formula I.

51 . The method of claim 50 , wherein the first flap primer of formula I and the second flap primer of formula I are the same.

52 . The method of claim 49 , wherein the primer of step (c)(i) is a MGB-primer.

53 . The method of claim 49 , wherein the primer of step (c)(ii) is a detection primer further comprising a fluorophore, wherein the fluorophore is quenched by the MGB and insertion of the MGB into a minor groove unquenches the fluorophore.

54 . A method for amplification of a target nucleic acid in a sample, the method comprising:

(a) contacting a sample suspected of containing the target nucleic acid with an amplification reaction mixture comprising:

a detection primer comprising a sequence complementary to the target nucleic acid, a minor groove binder, and fluorophore, wherein the fluorophore is quenched by the MGB and insertion of the MGB into a minor groove unquenches the fluorophore;

(b) incubating the reaction mixture under amplification conditions, thereby generating an amplified target nucleic acid; and

(c) optionally detecting the amplified target nucleic acid.

55 . The method of claim 54 , wherein the target nucleic acid is selected from the group consisting of DNA, mRNA, tRNA and rRNA.

56 . The method of claim 54 , wherein the target nucleic acid is less than 30 nucleotides in length.

57 . The method of claim 56 , wherein the target nucleic acid is selected from the group consisting of siRNA and miRNA.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2009
From: NANOGEN, INC.; EPOCH BIOSCIENCES, INC.; NANOTRONICS, INC.
To: ELITECH HOLDING B.V.
Reel/Frame 023260/0182 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2006
From: LOKHOV, SERGEY; MILLS, ALAN G.; LUKHTANOV, EUGENE
To: EPOCH BIOSCIENCES, INC.
Reel/Frame 018281/0915 →